Bone marrow transplantation - JoVE Visualize

Showing results (1111-1120 of 9,901) with videos related to

Pageof 991

Sort By:

Bone Marrow Transplantation|December 4, 2003

Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allograftsK Theilgaard-Mönch, K Raaschou-Jensen, K Schjødt, et al.

Bone Marrow Transplantation|December 4, 2003

Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effectE Alyea, E Weller, R Schlossman, et al.

Bone Marrow Transplantation|July 6, 2004

Psychosocial supportive care for children receiving stem cell transplantation: practice patterns across centersA C Sherman, S Simonton, U Latif, et al.

Bone Marrow Transplantation|July 6, 2004

A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantationJ Moore, D Ma, R Will, et al.

Bone Marrow Transplantation|July 13, 2004

Immunological and electrophysiological investigations of severe ptosis after bone marrow transplantationC Hon, W Mak, A K H Kwok, et al.

Bone Marrow Transplantation|August 1, 1992

What determines who develops graft-versus-host disease: the graft or the host (or both)?R P Gale, M M Horowitz, A Butturini, et al.

Bone Marrow Transplantation|June 15, 2004

Busulphan given as four single daily doses of 150 mg/m2 is safe and effective in children of all agesP J Shaw, C Nath, A Berry, et al.

Bone Marrow Transplantation|June 15, 2004

Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantationA Amsterdam, A Jakubowski, H Castro-Malaspina, et al.

Bone Marrow Transplantation|July 1, 1992

Proliferation rates in epidermis of patients with graft-versus-host disease, non-specific inflammation and normal skinJ Jakic-Razumovic, M D Browne, G E Sale

Bone Marrow Transplantation|July 1, 1992

Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrowB M Bär, A Schattenberg, A J De Man, et al.

Pageof 991

Showing results (1111-1120 of 9,901) with videos related to

Sort By:

Pageof 991

Bone Marrow Transplantation|December 4, 2003

Pluripotent and myeloid-committed CD34+ subsets in hematopoietic stem cell allograftsK Theilgaard-Mönch, K Raaschou-Jensen, K Schjødt, et al.

Bone Marrow Transplantation|December 4, 2003

Outcome after autologous and allogeneic stem cell transplantation for patients with multiple myeloma: impact of graft-versus-myeloma effectE Alyea, E Weller, R Schlossman, et al.

Bone Marrow Transplantation|July 6, 2004

Psychosocial supportive care for children receiving stem cell transplantation: practice patterns across centersA C Sherman, S Simonton, U Latif, et al.

Bone Marrow Transplantation|July 6, 2004

A phase II study of Rituximab in rheumatoid arthritis patients with recurrent disease following haematopoietic stem cell transplantationJ Moore, D Ma, R Will, et al.

Bone Marrow Transplantation|July 13, 2004

Immunological and electrophysiological investigations of severe ptosis after bone marrow transplantationC Hon, W Mak, A K H Kwok, et al.

Bone Marrow Transplantation|August 1, 1992

What determines who develops graft-versus-host disease: the graft or the host (or both)?R P Gale, M M Horowitz, A Butturini, et al.

Bone Marrow Transplantation|June 15, 2004

Busulphan given as four single daily doses of 150 mg/m2 is safe and effective in children of all agesP J Shaw, C Nath, A Berry, et al.

Bone Marrow Transplantation|June 15, 2004

Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantationA Amsterdam, A Jakubowski, H Castro-Malaspina, et al.

Bone Marrow Transplantation|July 1, 1992

Proliferation rates in epidermis of patients with graft-versus-host disease, non-specific inflammation and normal skinJ Jakic-Razumovic, M D Browne, G E Sale

Bone Marrow Transplantation|July 1, 1992

Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrowB M Bär, A Schattenberg, A J De Man, et al.

Pageof 991